Findings from 2 trials that compared various doses of the atypical antipsychotic brexpiprazole with placebo have indicated that the drug may have additional benefits for patients with agitation due to...
Researchers recently compared the effects of treatment with an atypical antipsychotic vs placebo for various periods of time among patients with Alzheimer disease psychosis.
In a recent systematic review, researchers evaluated data from 36 studies regarding the safety, efficacy, and tolerability of pharmaceutical-grade cannabidiol for the treatment of drug-resistant epilepsy in...
In 2006, the US Food and Drug Administration issued an advisory that warned of the risk for serotonin syndrome with concomitant use of triptans and certain antidepressants. In a recent study, researchers...
Currently, little information is available regarding the clinical significance of anosognosia for cognitive decline in patients with mild cognitive impairment. In a new study, researchers assessed this...
Given the prevalence of injury and long-term health consequences among former professional athletes, the authors of a new study aimed to investigate potential differences in long-term mortality among career...
Previous evidence has indicated that tocotrienols may reduce neuropathic symptoms. In a new study, researchers evaluated their effect on symptom management in patients with diabetic peripheral neuropathy.
...
Findings from a new study have clarified the potential associations of migraine with various adverse cardiovascular events including myocardial infarction, ischemic stroke, and venous thromboembolism.
